南微医学: directors' dealings · France · AMF SSE:688029 FR FR · AMF Mcap 15.3Bn€
Explore the full management transaction log of 南微医学, a listed issuer based in France. Shares are listed on FR FR, under the supervision of AMF. Market capitalisation: €15.3bn. The latest transaction was filed on 1 December 2023 — Sale. Among the most active insiders: 芮晨为. All data is openly available.
Financial data FY ended December 2025 · cache
Income statement
Revenue 3.18 Bn€
Gross profit 2.04 Bn€ 64% margin
Net income 570.3 M€ 17.9% margin
Balance sheet & cash
Market cap 15.32 Bn€
Total debt 241.2 M€
Free Cash Flow 433.0 M€
Last declaration on 1 December 2023
Declarations 16 total
Executives ● Sale7 SSE
250,000 shares
SSE:173000007143192580 · 1 Dec 2023
Executives ● Purchase2 SSE
2,052 shares
SSE:173000005804796800 · 23 Aug 2022
Ideal exit: 20 May 2023 (T+270) Executives ● Purchase11 SSE
6,750 shares
SSE:173000005457336060 · 22 Dec 2021
Ideal exit: 18 Sept 2022 (T+270) Executives ● Purchase7 SSE
12,600 shares
SSE:173000005457335940 · 22 Dec 2021
Ideal exit: 18 Sept 2022 (T+270) Executives ● Purchase11 SSE
8,400 shares
SSE:173000005457335900 · 22 Dec 2021
Ideal exit: 18 Sept 2022 (T+270) Executives ● Purchase11 SSE
12,600 shares
SSE:173000005457336100 · 22 Dec 2021
Ideal exit: 18 Sept 2022 (T+270) Executives ● Purchase2 SSE
3,600 shares
SSE:173000005457336000 · 22 Dec 2021
Ideal exit: 18 Sept 2022 (T+270) Executives ● Purchase2 SSE
6,750 shares
SSE:173000005457336160 · 22 Dec 2021
Ideal exit: 18 Sept 2022 (T+270) Executives ● Purchase11 SSE
6,750 shares
SSE:173000005457335970 · 22 Dec 2021
Ideal exit: 18 Sept 2022 (T+270) Executives ● Purchase11 SSE
6,750 shares
SSE:173000005457336130 · 22 Dec 2021
Ideal exit: 18 Sept 2022 (T+270) Executives ● Purchase7 SSE
21,000 shares
SSE:173000005457336030 · 22 Dec 2021
Ideal exit: 18 Sept 2022 (T+270) Executives ● Sale11 SSE
40,000 shares
SSE:173000004436548100 · 26 May 2021
Executives ● Sale7 SSE
8,108 shares
SSE:173000004441629900 · 26 May 2021
Executives ● Sale7 SSE
118,946 shares
SSE:173000004441633570 · 25 May 2021
Executives ● Sale11 SSE
51,500 shares
SSE:173000004441223600 · 24 May 2021
Executives ● Sale11 SSE
6,000 shares
SSE:173000004432459700 · 21 May 2021
